DEVELOPMENT OF A DE NOVO MODEL TO ASSESS THE COST-EFFECTIVENESS OF A NEW TREATMENT OPTION FOR PATIENTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY (IGAN)

被引：0
|
作者：
Davies, N. [1 ]
Dickinson, O. [1 ]
Downward, L. [2 ]
Pitcher, D. [2 ]
Gale, D. [3 ]
Ioannou, P. [1 ]
Kipentzoglou, K. [4 ]
Crabtree, M. [5 ]
机构：
[1] Mtech Access Ltd, Bicester, England
[2] UK Renal Registry, Bristol, BST, England
[3] UCL, London, England
[4] Britannia Pharmaceut Ltd, Reading, England
[5] STADA, Bad Vilbel, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE119
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States
    Ramjee, Lauren
    Vurgun, Nesrin
    Ngai, Christopher
    Patel, Mit
    Tremblay, Gabriel
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 213 - 226
  • [2] DEVELOPMENT OF AN ECONOMIC MODEL TO ASSESS THE COST-EFFECTIVENESS OF NITISINONE AS A TREATMENT FOR ALKAPTONURIA IN THE UK
    McCarron, C.
    VALUE IN HEALTH, 2016, 19 (07) : A589 - A589
  • [3] A model to assess the cost-effectiveness of new treatments for depression
    Sobocki, P.
    Ekman, M.
    Agren, H.
    Jonsson, B.
    VALUE IN HEALTH, 2006, 9 (06) : A321 - A321
  • [4] Model to assess the cost-effectiveness of new treatments for depression
    Sobocki, Patrik
    Ekman, Mattias
    Agren, Hans
    Jonsson, Bengt
    Rehnberg, Clas
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2006, 22 (04) : 469 - 477
  • [5] Cost-Effectiveness of de novo Simvastatin as Adjunctive Therapy in Patients Ill with
    Eladawy, Sara Mostafa
    Elgendy, Mohamed Abd Alsalam
    Zaki, Mamdouh Ahmed
    Bazan, Naglaa Samir
    AMERICAN HEALTH AND DRUG BENEFITS, 2022, 15 (04): : 118 - 126
  • [6] A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies
    de Albornoz, Sara Carrillo
    Chai, Khai Li
    Higgins, Alisa M.
    Petrie, Dennis
    Wood, Erica M.
    McQuilten, Zoe K.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)
  • [7] DEVELOPMENT OF AN EARLY ECONOMIC MODEL TO ASSESS THE COST-EFFECTIVENESS OF A NOVEL TECHNOLOGY FOR THE TREATMENT AND/OR PREVENTION OF CATARACTS
    Looby, A.
    Butler, K.
    Hillcoat, L.
    VALUE IN HEALTH, 2023, 26 (12) : S434 - S434
  • [8] A probabilistic model to assess the cost-effectiveness of a new statin (Rosuvastatin) in the UK
    Palmer, S
    Brady, AJ
    Ratcliffe, A
    VALUE IN HEALTH, 2003, 6 (06) : 649 - 650
  • [9] Effectiveness and Cost-Effectiveness of Antidepressants in Primary Care: A Multiple Treatment Comparison Meta-Analysis and Cost-Effectiveness Model
    Ramsberg, Joakim
    Asseburg, Christian
    Henriksson, Martin
    PLOS ONE, 2012, 7 (08):
  • [10] Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia
    Ford, Emily
    Adams, Jon
    Graves, Nicholas
    BMJ OPEN, 2012, 2 (05):
12345